Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Supreme Court
Pharma
With Chevron gone, multitude of legal challenges await FDA, CMS
An expert recently discussed the ramifications of the Supreme Court's Chevron doctrine ruling during a Fierce Pharma podcast interview.
Kevin Dunleavy
Aug 27, 2024 8:40am
Appeals court again strikes down J&J's Texas two-step ploy
Jul 26, 2024 11:48am
Amarin, after stock crash and layoffs, revives patent lawsuit
Jun 26, 2024 1:01pm
Supreme Court grants mulligan in terrorism-funding case
Jun 24, 2024 3:31pm
Industry commends Supreme Court's mifepristone ruling
Jun 14, 2024 2:42pm
Supreme Court rejects Vanda's Hetlioz patent revival appeal
Apr 22, 2024 3:49pm
